Meihai X. Deng
No. 600, Tianhe Road
Guangzhou, 510530, China
Guangzhou, 510530, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Liquid biopsy-based multi-omics approach for early detection of hepatocellular carcinoma (ASCEND-Hep): a multiphase prospective development and validation study.
Journal: BMC medicine
Published: January 07, 2026
Clinical and molecular genetic analysis of nine patients with neonatal Dubin-Johnson syndrome
Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
Published: June 18, 2025
Exosome-derived hsa_circ_0007132 promotes lenvatinib resistance by inhibiting the ubiquitin-mediated degradation of NONO.
Journal: Non-coding RNA research
Published: February 17, 2025
Late course adaptive radiotherapy based on tumor volume reduction decreases Gastrointestinal toxicity for abdominal lymph node metastasis of hepatocellular carcinoma.
Journal: Scientific reports
Published: February 11, 2025
Machine learning-assisted multi-dimensional transcriptomic analysis of cytoskeleton-related molecules and their relationship with prognosis in hepatocellular carcinoma.
Journal: Scientific reports
Published: February 11, 2025
Exosome-derived lnc-FAM72D-3 promotes lenvatinib resistance by remodeling hepatocellular carcinoma cytoskeleton via MBNL1/FAK axis.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: January 22, 2025
Post-treatment adverse events ranking in targeted immunotherapy for hepatocellular carcinoma: A network meta-analysis based on risk probability assessment.
Journal: Critical reviews in oncology/hematology
Published: December 08, 2024
Full-cycle, multidisciplinary and systematic management of citrin deficiency
Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
Published: October 07, 2024
CircRNA-mTOR Promotes Hepatocellular Carcinoma Progression and Lenvatinib Resistance Through the PSIP1/c-Myc Axis.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 01, 2024
CircPIK3C3 inhibits hepatocellular carcinoma progression and lenvatinib resistance by suppressing the Wnt/β-catenin pathway via the miR-452-5p/SOX15 axis.
Journal: Genomics
Published: April 22, 2024
A new strategy for overcoming drug resistance in liver cancer: Epigenetic regulation.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 09, 2024
Efficacy and safety of low-dose cyclophosphamide combined with lenvatinib, pembrolizumab and TACE for unresectable hepatocellular carcinoma: A single-center, prospective, single-arm clinical trial.
Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu
Published: November 17, 2023
Last Updated: 09/26/2026